Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-08-16 Purchase |
2021-08-18 06:05 am |
Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO |
3,000 | $3.56 | $10,680 | 207,732 (Direct) |
View |
| 2021-08-13 Purchase |
2021-08-17 5:01 pm |
Tracon Pharmaceuticals Inc. | TCON | Brown Scott B. Chief Financial Officer |
1,000 | $3.6946 | $3,695 | 7,628 (Direct) |
View |
| 2021-07-26 Purchase |
2021-07-27 06:00 am |
Tracon Pharmaceuticals Inc. | TCON | PELLETIER SAUNDRA L Director |
6,545 | $3.82 | $25,002 | 12,045 (Direct) |
View |
| 2021-07-26 Purchase |
2021-07-27 06:00 am |
Tracon Pharmaceuticals Inc. | TCON | LARUE WILLIAM R Director |
6,545 | $3.82 | $25,002 | 7,883 (Direct) |
View |
| 2021-03-08 Purchase |
2021-03-09 06:00 am |
Tracon Pharmaceuticals Inc. | TCON | Brown Scott B. Chief Financial Officer |
1,000 | $8.2956 | $8,296 | 3,128 (Direct) |
View |
| 2021-01-27 Purchase |
2021-01-28 06:00 am |
Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO |
11,000 | $8.9792 | $98,771 | 201,232 (Direct) |
View |
| 2020-12-30 Purchase |
2020-12-30 6:24 pm |
Tracon Pharmaceuticals Inc. | TCON | Ikarian Capital LLC Ikarian Healthcare Master Fund L.P. Ikarian Healthcare Fund GP L.P. Chart Westcott Living Trust Shahrestani Neil Member of 10% Group 10% Owner |
520,291 | $9.61 | $4,999,997 | 2,716,840 (Indirect) |
View |
| 2020-12-29 Purchase |
2020-12-30 06:00 am |
Tracon Pharmaceuticals Inc. | TCON | WIGGINS MARK C Chief Business Officer |
1,000 | $10.57 | $10,570 | 13,700 (Direct) |
View |
| 2020-12-29 Purchase |
2020-12-30 06:00 am |
Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO |
1,000 | $9.98 | $9,980 | 190,232 (Direct) |
View |
| 2020-12-22 Purchase |
2020-12-28 09:53 am |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
496,277 | $8.06 | $3,999,993 | 5,766,877 (Indirect) |
View |
| 2020-10-29 Purchase |
2020-11-12 6:18 pm |
Tracon Pharmaceuticals Inc. | TCON | Ikarian Capital LLC Ikarian Healthcare Master Fund L.P. Ikarian Healthcare Fund GP L.P. Chart Westcott Living Trust Shahrestani Neil Member of 10% Group 10% Owner |
34,000 | $5.0962 | $173,269 | 2,196,549 (Indirect) |
View |
| 2020-10-21 Purchase |
2020-10-23 9:30 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
8,656 | $4.3969 | $38,060 | 5,045,600 (Indirect) |
View |
| 2020-10-21 Purchase |
2020-10-23 06:00 am |
Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO |
2,000 | $4.3845 | $8,769 | 189,232 (Direct) |
View |
| 2020-09-23 Purchase |
2020-09-25 9:30 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
78,734 | $4.726 | $372,095 | 5,033,944 (Indirect) |
View |
| 2020-09-23 Purchase |
2020-09-25 06:00 am |
Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO |
5,000 | $4.7198 | $23,599 | 186,882 (Direct) |
View |
| 2020-09-04 Purchase(A) |
2020-09-17 9:22 pm |
Tracon Pharmaceuticals Inc. | TCON | Ikarian Capital LLC Ikarian Healthcare Master Fund L.P. Ikarian Healthcare Fund GP L.P. Chart Westcott Living Trust Shahrestani Neil Member of 10% Group 10% Owner |
322,471 | $3.279 | $1,057,387 | 2,162,549 (Indirect) |
View |
| 2020-09-04 Purchase |
2020-09-15 9:19 pm |
Tracon Pharmaceuticals Inc. | TCON | Ikarian Capital LLC Ikarian Healthcare Master Fund L.P. Shahrestani Neil Member of 10% Group 10% Owner |
322,471 | $3.279 | $1,057,387 | 2,162,549 (Indirect) |
View |
| 2020-09-10 Purchase |
2020-09-14 1:49 pm |
Tracon Pharmaceuticals Inc. | TCON | WIGGINS MARK C Chief Business Officer |
7,000 | $4.1361 | $28,953 | 12,350 (Direct) |
View |
| 2020-09-04 Purchase |
2020-09-09 6:15 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
56,558 | $3.3753 | $190,902 | 4,957,944 (Indirect) |
View |
| 2020-09-04 Purchase |
2020-09-09 06:00 am |
Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO |
10,000 | $2.575 | $25,750 | 181,882 (Direct) |
View |
| 2020-09-01 Purchase |
2020-09-03 5:15 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
159,800 | $2.2768 | $363,825 | 4,904,452 (Indirect) |
View |
| 2020-08-27 Purchase |
2020-08-31 9:36 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
545,504 | $1.7422 | $950,378 | 4,750,852 (Indirect) |
View |
| 2020-08-21 Purchase |
2020-08-25 06:00 am |
Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO |
5,325 | $1.56 | $8,307 | 171,882 (Direct) |
View |
| 2020-08-20 Purchase |
2020-08-24 06:06 am |
Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO |
30,000 | $1.58 | $47,400 | 166,557 (Direct) |
View |
| 2020-08-14 Purchase |
2020-08-18 8:28 pm |
Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO |
44,843 | $1.6284 | $73,021 | 136,557 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-06-10 Option Award |
2021-06-24 7:01 pm |
N/A 2031-06-09 |
Tracon Pharmaceuticals Inc. | TCON | Johnson-Pratt Lisa Director |
10,500 | $0 | 10,500 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-24 7:01 pm |
N/A 2031-06-09 |
Tracon Pharmaceuticals Inc. | TCON | MATTINGLY MARTIN A Director |
10,500 | $0 | 10,500 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-24 7:01 pm |
N/A 2031-06-09 |
Tracon Pharmaceuticals Inc. | TCON | PELLETIER SAUNDRA L Director |
10,500 | $0 | 10,500 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-24 7:01 pm |
N/A 2031-06-09 |
Tracon Pharmaceuticals Inc. | TCON | LARUE WILLIAM R Director |
10,500 | $0 | 10,500 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-24 7:00 pm |
N/A 2031-06-09 |
Tracon Pharmaceuticals Inc. | TCON | WORLAND STEPHEN T Director |
10,500 | $0 | 10,500 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-24 7:00 pm |
N/A 2031-06-09 |
Tracon Pharmaceuticals Inc. | TCON | Twiford J Rainer Director |
10,500 | $0 | 10,500 (Direct) |
View |
| 2021-03-02 Option Award |
2021-03-08 4:50 pm |
N/A 2031-03-01 |
Tracon Pharmaceuticals Inc. | TCON | Johnson-Pratt Lisa Director |
21,000 | $0 | 21,000 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-02 6:00 pm |
N/A 2031-01-28 |
Tracon Pharmaceuticals Inc. | TCON | Brown Scott B. Chief Accounting Officer (PAO) |
55,000 | $0 | 55,000 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-02 6:00 pm |
N/A 2031-01-28 |
Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO |
180,000 | $0 | 180,000 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-02 6:00 pm |
N/A 2031-01-28 |
Tracon Pharmaceuticals Inc. | TCON | WIGGINS MARK C Chief Business Officer |
55,000 | $0 | 55,000 (Direct) |
View |
Ownership |
2020-09-17 9:19 pm |
N/A N/A |
Tracon Pharmaceuticals Inc. | TCON | Chart Westcott Living Trust Ikarian Healthcare Master Fund L.P. Ikarian Healthcare Fund GP L.P. Shahrestani Neil Member of 10% Group 10% Owner |
0 | $0 | 1,840,078 (Indirect) |
View |
Ownership |
2020-09-14 6:49 pm |
N/A N/A |
Tracon Pharmaceuticals Inc. | TCON | Ikarian Capital LLC Member of 10% Group 10% Owner |
0 | $0 | 1,840,078 (Indirect) |
View |
Ownership |
2020-08-31 9:33 pm |
N/A N/A |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
0 | $0 | 3,062,355 (Indirect) |
View |